Cannabinoid receptor stimulation increases motivation for nicotine and nicotine seeking

Addiction Biology

Volumn 17, Issue 1, 2012, Pages 47-61

  Gamaleddin, Islam ^a   Wertheim, Carrie ^b   Zhu, Andy Z X ^a   Coen, Kathleen M ^a   Vemuri, Kiran ^d   Makryannis, Alex ^d   Goldberg, Steven R ^b   Le Foll, Bernard ^a,c  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d NORTHEASTERN UNIVERSITY   (United States)

Author keywords

212 2; Cannabinoid; discrimination; nicotine; relapse; self administration; WIN 55

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; CANNABINOID RECEPTOR; NICOTINE; RIMONABANT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANNABINOID RECEPTOR STIMULATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DISCRIMINATION; DRUG EFFECT; DRUG MECHANISM; DRUG SEEKING BEHAVIOR; MALE; MOTIVATION; NONHUMAN; PERFORMANCE; PRIORITY JOURNAL; RAT; REINFORCEMENT; STIMULATION;

ANALGESICS, OPIOID; ANIMALS; BEHAVIOR, ADDICTIVE; BEHAVIOR, ANIMAL; BENZOXAZINES; CONDITIONING, OPERANT; CUES; DISCRIMINATION (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXTINCTION, PSYCHOLOGICAL; FEEDING BEHAVIOR; MALE; MORPHOLINES; MOTIVATION; MOTOR ACTIVITY; NAPHTHALENES; NICOTINE; PIPERIDINES; PYRAZOLES; RATS; RATS, LONG-EVANS; RATS, SPRAGUE-DAWLEY; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION; TOBACCO USE DISORDER;

EID: 80052236978     PISSN: 13556215     EISSN: 13691600     Source Type: Journal    
DOI: 10.1111/j.1369-1600.2011.00314.x     Document Type: Article

References (53)

1. Anggadiredja K, Nakamichi M, Hiranita T, Tanaka H, Shoyama Y, Watanabe S, Yamamoto T, (2004) Endocannabinoid system modulates relapse to methamphetamine seeking: possible mediation by the arachidonic acid cascade. Neuropsychopharmacology 29: 1470-1478. (Pubitemid 38982239)
2. Arnold JM, Roberts DC, (1997) A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement. Pharmacol Biochem Behav 57: 441-447. (Pubitemid 27296755)
3. Balerio GN, Aso E, Berrendero F, Murtra P, Maldonado R, (2004) Delta9-tetrahydrocannabinol decreases somatic and motivational manifestations of nicotine withdrawal in mice. Eur J Neurosci 20: 2737-2748. (Pubitemid 39573789)
4. Balerio GN, Aso E, Maldonado R, (2006) Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology (Berl) 184: 504-513. (Pubitemid 43255867)
5. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D, (1997) Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277: 1094-1097. (Pubitemid 27371630)
6. Buczek Y, Le AD, Stewart J, Shaham Y, (1999) Stress reinstates nicotine seeking but not sucrose solution seeking in rats. Psychopharmacology (Berl) 144: 183-188. (Pubitemid 29264435)
7. Castañé A, Berrendero F, Maldonado R, (2005) The role of the cannabinoid system in nicotine addiction. Pharmacol Biochem Behav 81: 381-386. (Pubitemid 40807135)
8. Cohen C, Kodas E, Griebel G, (2005) CB1 receptor antagonists for the treatment of nicotine addiction. Pharmacol Biochem Behav 81: 387-395. (Pubitemid 40807136)
9. Cohen C, Perrault G, Voltz C, Steinberg R, Soubrie P, (2002) SR141716, a central cannabinoid (CB(1)) receptor antagonist, blocks the motivational and dopamine-releasing effects of nicotine in rats. Behav Pharmacol 13: 451-463. (Pubitemid 35178842)
10. Corrigall WA, Coen KM, (1989) Nicotine maintains robust self-administration in rats on a limited-access schedule. Psychopharmacology (Berl) 99: 473-478. (Pubitemid 19273101)
11. Cossu G, Ledent C, Fattore L, Imperato A, Bohme GA, Parmentier M, Fratta W, (2001) Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse. Behav Brain Res 118: 61-65. (Pubitemid 32037114)
12. De Vries TJ, Homberg JR, Binnekade R, Raaso H, Schoffelmeer AN, (2003) Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berl) 168: 164-169. (Pubitemid 36851175)
13. De Vries TJ, Schoffelmeer AN, (2005) Cannabinoid CB1 receptors control conditioned drug seeking. Trends Pharmacol Sci 26: 420-426. (Pubitemid 41039218)
14. De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vanderschuren LJ, Schoffelmeer AN, (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7: 1151-1154. (Pubitemid 33010025)
15. Donny EC, Caggiula AR, Mielke MM, Booth S, Gharib MA, Hoffman A, Maldovan V, Shupenko C, McCallum SE, (1999) Nicotine self-administration in rats on a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 147: 135-142. (Pubitemid 30010560)
16. Donny EC, Caggiula AR, Mielke MM, Jacobs KS, Rose C, Sved AF, (1998) Acquisition of nicotine self-administration in rats: the effects of dose, feeding schedule, and drug contingency. Psychopharmacology (Berl) 136: 83-90. (Pubitemid 28097524)
17. Fattore L, Martellotta MC, Cossu G, Mascia MS, Fratta W, (1999) CB1 cannabinoid receptor agonist WIN 55,212-2 decreases intravenous cocaine self-administration in rats. Behav Brain Res 104: 141-146. (Pubitemid 29421642)
18. Fattore L, Spano MS, Cossu G, Deiana S, Fratta W, (2003) Cannabinoid mechanism in reinstatement of heroin-seeking after a long period of abstinence in rats. Eur J Neurosci 17: 1723-1726. (Pubitemid 36628140)
19. Forget B, Barthelemy S, Saurini F, Hamon M, Thiebot MH, (2006) Differential involvement of the endocannabinoid system in short- and long-term expression of incentive learning supported by nicotine in rats. Psychopharmacology (Berl) 189: 59-69. (Pubitemid 44607260)
20. Forget B, Coen KM, Le Foll B, (2009) Inhibition of fatty acid amide hydrolase reduces reinstatement of nicotine seeking but not break point for nicotine self-administration-comparison with CB(1) receptor blockade. Psychopharmacology (Berl) 205: 613-624.
21. Forget B, Hamon M, Thiebot MH, (2005) Cannabinoid CB1 receptors are involved in motivational effects of nicotine in rats. Psychopharmacology (Berl) 181: 722-734. (Pubitemid 41400758)
22. Forget B, Pushparaj A, Le Foll B, (2010a) Granular insular cortex inactivation as a novel therapeutic strategy for nicotine addiction. Biological Psychiatry online. 68: 265-271.
23. Forget B, Wertheim C, Mascia P, Pushparaj A, Goldberg SR, Le Foll B, (2010b) Noradrenergic α1 receptors as a novel target for the treatment of nicotine addiction. Neuropsychopharmacology online. 35: 1751-1760.
24. Gobbi G, Bambico FR, Mangieri R, Bortolato M, Campolongo P, Solinas M, Cassano T, Morgese MG, Debonnel G, Duranti A, Tontini A, Tarzia G, Mor M, Trezza V, Goldberg SR, Cuomo V, Piomelli D, (2005) Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis. Proc Natl Acad Sci USA 102: 18620-18625. (Pubitemid 43011275)
25. Haller J, Varga B, Ledent C, Freund TF, (2004) CB1 cannabinoid receptors mediate anxiolytic effects: convergent genetic and pharmacological evidence with CB1-specific agents. Behav Pharmacol 15: 299-304. (Pubitemid 39062560)
26. Hayase T, Yamamoto Y, Yamamoto K, (2005) Persistent anxiogenic effects of a single or repeated doses of cocaine and methamphetamine: interactions with endogenous cannabinoid receptor ligands. Behav Pharmacol 16: 395-404. (Pubitemid 41404811)
27. Higgs S, Barber DJ, Cooper AJ, Terry P, (2005) Differential effects of two cannabinoid receptor agonists on progressive ratio responding for food and free-feeding in rats. Behav Pharmacol 16: 389-393. (Pubitemid 41404810)
28. Justinova Z, Ferré S, Barnes C, Wertheim CE, Pappas LA, Goldberg SR, Le Foll B, (2009) Effects of chronic caffeine exposure on the involvement of adenosine A1 and A2A receptors in the discriminative-stimulus effects of nicotine, methamphetamine and cocaine in rats. Psychopharmacology (Berl) 203: 355-367.
29. Kathuria S, Gaetani S, Fegley D, Valino F, Duranti A, Tontini A, et al,. (2003) Modulation of anxiety through blockade of anandamide hydrolysis. Nat Med 9: 76-81. (Pubitemid 36098263)
30. Khaled MA, Farid Araki K, Li B, Coen KM, Marinelli PW, Varga J, et al,. (2010) The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking. Int J Neuropsychopharmacol 13: 181-190.
31. Kumar R, Reavill C, Stolerman IP, (1987) Nicotine cue in rats: effects of central administration of ganglion-blocking drugs. Br J Pharmacol 90: 239-246. (Pubitemid 17235615)
32. Le Foll B, Forget B, Aubin HJ, Goldberg SR, (2008a) Blocking cannabinoid CB1 receptors for the treatment of nicotine dependence: insights from pre-clinical and clinical studies. Addict Biol 13: 239-252. (Pubitemid 351692986)
33. 1 antagonist, blocks nicotine-conditioned place preferences. Neuroreport 15: 2139-2143. (Pubitemid 39281762)
34. 1 receptor antagonists as promising new medications for drug dependence. J Pharmacol Exp Ther 312: 875-883. (Pubitemid 40293744)
35. Le Foll B, Goldberg SR, (2005b) Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology (Berl) 178: 481-492. (Pubitemid 40486988)
36. Le Foll B, Gorelick DA, Goldberg SR, (2009) The future of endocannabinoid-oriented clinical research after CB1 antagonists. Psychopharmacology (Berl) 205: 171-174.
37. Le Foll B, Sokoloff P, Stark H, Goldberg SR, (2005) Dopamine D3 ligands block nicotine-induced conditioned place preferences through a mechanism that does not involve discriminative-stimulus or antidepressant-like effects. Neuropsychopharmacology 30: 720-730. (Pubitemid 40397078)
38. Le Foll B, Wertheim C, Goldberg SR, (2007) High reinforcing efficacy of nicotine in non-human primates. PLoS ONE 2: e230.
39. Le Foll B, Wertheim CE, Goldberg SR, (2008b) Effects of baclofen on conditioned rewarding and discriminative stimulus effects of nicotine in rats. Neuroscience Lett 443: 236-240.
40. National Research Council (2003) Guidelines for the Care and Use of Mammals in Neuroscience and Behavioral Research. Washington, DC: The National Academy Press US.
41. Pertwee RG, Stevenson LA, Griffin G, (1993) Cross-tolerance between delta-9-tetrahydrocannabinol and the cannabimimetic agents, CP 55,940, WIN 55,212-2 and anandamide. Br J Pharmacol 110: 1483-1490. (Pubitemid 23360982)
42. Pisanu A, Acquas E, Fenu S, Di Chiara G, (2006) Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by mu opioid and D(1) dopamine receptors. Neuropharmacology 50: 661-670.
43. Pratt JA, Stolerman IP, Garcha HS, Giardini V, Feyerabend C, (1983) Discriminative stimulus properties of nicotine: further evidence for mediation at a cholinergic receptor. Psychopharmacology (Berl) 81: 54-60. (Pubitemid 13038262)
44. Roberts DC, Bennett SA, (1993) Heroin self-administration in rats under a progressive ratio schedule of reinforcement. Psychopharmacology (Berl) 111: 215-218. (Pubitemid 23135082)
45. Scherma M, Fadda P, Le Foll B, Forget B, Fratta W, Goldberg SR, et al,. (2008a) The endocannabinoid system: a new molecular target for the treatment of tobacco addiction. CNS Neurol Disord Drug Targets 7: 468-481.
46. Scherma M, Panlilio LV, Fadda P, Fattore L, Gamaleddin I, Le Foll B, et al,. (2008b) Inhibition of anandamide hydrolysis by URB597 reverses abuse-related behavioral and neurochemical effects of nicotine in rats. J Pharmacol Exp Ther 327: 482-490.
47. Shoaib M, (2008) The cannabinoid antagonist AM251 attenuates nicotine self-admininstration and nicotine-seeking behaviour in rats. Neuropharmacology 52: 438-444.
48. Solinas M, Goldberg SR, (2005) Motivational effects of cannabinoids and opioids on food reinforcement depend on simultaneous activation of cannabinoid and opioid systems. Neuropsychopharmacology 30: 2035-2045. (Pubitemid 43093503)
49. Spano MS, Fattore L, Cossu G, Deiana S, Fadda P, Fratta W, (2004) CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat. Br J Pharmacol 143: 343-350. (Pubitemid 39424822)
50. Spivak CE, Lupica CR, Oz M, (2007) The endocannabinoid anandamide inhibits the function of alpha4beta2 nicotinic acetylcholine receptors. Mol Pharmacol 72: 1024-1032. (Pubitemid 47481425)
51. Stolerman IP, Garcha HS, Pratt JA, Kumar R, (1984) Role of training dose in discrimination of nicotine and related compounds by rats. Psychopharmacology (Berl) 84: 413-419. (Pubitemid 15205971)
52. Valjent E, Mitchell JM, Besson MJ, Caboche J, Maldonado R, (2002) Behavioural and biochemical evidence for interactions between Delta 9-tetrahydrocannabinol and nicotine. Br J Pharmacol 135: 564-578. (Pubitemid 34151189)
53. Zaniewska M, McCreary AC, Przegalinski E, Filip M, (2006) Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. Eur J Pharmacol 540: 96-106. (Pubitemid 43866706)